Perseus Holdings
Austin, Texas, United States
About Perseus Holdings
Perseus Holdings is an immuno-oncology company that is focused on the development and commercialization of immune-mediated technologies for the treatment of cancer. The company holds executive licenses for the tumor lysate, particle-loaded, dendritic cell (TLPLDC) vaccine, and the tumor lysate, particle only (TLPO) vaccine – both personalized therapeutic cancer vaccines designed to attack cancer cells by igniting innate and adaptive immune responses which increase a patient's own production of T cells to fight their specific cancer. Perseus Holdings was founded in 2014 and is based in Austin, Texas.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $2.4M
- Last round: Series Unknown (Mar 2015)
- Website: perseusholdingsusa.com
Industries & Categories
Biotechnology, Commercial, Health Care, Oncology, Wellness
Canonical: https://fsome.com/organization/perseus-holdings-2456945 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.